13F

Stock

Intellia Therapeutics, Inc.

NTLA · held by 14 managers

Reported value

$137.9M

Holders

14

+3 new · −2 exited

Holders’ est. mark

$3.86M

Price effect on 3 books still in the name

Largest holder

$104M

MORGAN STANLEY

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
MORGAN STANLEY6.02M$104M—Held
FARALLON CAPITAL MANAGEMENT LLC607.2K$10.5M—New
BANK OF AMERICA CORP /DE/605.5K$10.5M—Held
BARCLAYS PLC488.2K$8.43M$3.85MAdded$3.57M
Hudson Bay Capital Management LP230K$3.97M—Held
NWAM LLC10.5K$293.8K—New
Sanctuary Advisors, LLC25.5K$181.4K—New
Allworth Financial LP984$17K—Held
Leonteq Securities AG890$15.4K$7.02KCut−$30.6K
IFP Advisors, Inc796$13.7K—Held
AllSquare Wealth Management LLC715$12.3K—Held
Essential Partners LLC487$8.41K$3.72KAdded$3.99K
MV CAPITAL MANAGEMENT, INC.54$933—Held
KBC Group NV6.09K$105—Held

Who left

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.